Parameter | Conservative management | Misoprostol | D&C | P value |
---|---|---|---|---|
N of patients | 78 | 61 | 84 | |
Time from miscarriage cycle (months) | 5.4 ± 3.5 (4(3–6)) | 5.1 ± 2.4(5(3–6)) | 5.9 ± 2.9(5(4–7)) | 0.43 |
Fresh consecutive cycle | 28/78(35.9%) | 29/61(47.5%) | 40/84(47.6%) | 0.24 |
Frozen-thawed consecutive cycle | 50/78(64.1%) | 32/61(52.5%) | 44/84(52.4%) | 0.24 |
Peak Estradiol levels (fresh cycle; pmol/l) | 4527.7 ± 2706.9(4268(3047–6472)) | 5164.9 ± 3639.4(4821(3528–6599) | 4805.7 ± 2706.1(3961(2042–5623)) | 0.56 |
Grade A embryos (%) | 27.1 + 37.7 | 28.0 + 36.2 | 31.3 + 36.1 | 0.91 |
Grade B embryos (%) | 47.6 + 43.3 | 58.0 + 40.6 | 45.2 + 38.9 | 0.70 |
Grade C embryos (%) | 6.3 + 18.8 | 1.3 + 3.7 | 10.1 + 22.8 | 0.21 |
N of transferred embryos | 1.6 ± 0.8(2(1–2)) | 1.7 ± 0.8(2(1–2)) | 2.0 ± 1.0(2(1–3)) | 0.41 |
ET (mm) at day of hCG/LH/P | 9.9 ± 2.1(10(8–11)) | 10.3 ± 2.3(10(9–11)) | 9.1 ± 2.4(10(9–11)) | 0.005b |
Comparison of ET between miscarriage cycle and consecutive cyclea | ||||
Difference at day of hCG/LH/P (mm) | 0.0 ± 1.7(0(−1–1)) | 0.2 ± 2.2(0(−1–1)) | −1.0 ± 2.4(−1(−2–0)) | 0.002b |
% of change at day of hCG/LH/P | −0.9 ± 17.4(1(− 8–10)) | 3.5 ± 21.7(0(−8–10)) | −8.2 ± 22.3(−8(−25–3)) | 0.001b |
Decrease of > 2 mm in ET at day of hCG/LH/P | 11/78(14.1%) C | 4/61(6.6%) C | 25/84(29.8%) | < 0.001 |
Reproductive outcomes | ||||
Implantation rate | 32/105 (30.5%)C | 18/102 (17.7%) | 16/144 (11.1%) | < 0.001 |
Clinical pregnancy rate | 30/78 (38.5%)C | 17/61 (27.9%) | 14/84 (16.7%) | 0.008 |
Miscarriage rate | 12/30 (40.0%) | 7/17 (41.2%) | 5/14 (35.7%) | 0.947 |
Live birth rate | 18/78 (23.1%) | 10/61 (16.4%) | 9/84 (10.7%) | 0.107 |